TLDR Palantir CEO Alex Karp said Anthropic and other frontier AI labs don’t understand real enterprise deployment Karp claimed most of what Anthropic talks aboutTLDR Palantir CEO Alex Karp said Anthropic and other frontier AI labs don’t understand real enterprise deployment Karp claimed most of what Anthropic talks about

Palantir (PLTR) Stock: CEO Karp Says Anthropic Is “Running on Palantir” — Investors Take Note

2026/06/11 21:33
3 min read
For feedback or concerns regarding this content, please contact us at [email protected]

TLDR

  • Palantir CEO Alex Karp said Anthropic and other frontier AI labs don’t understand real enterprise deployment
  • Karp claimed most of what Anthropic talks about publicly runs on Palantir’s platform
  • PLTR stock was up 0.64% in premarket Thursday, trading around $131.04
  • The stock is down 26.75% year to date and sits below all major moving averages
  • Wall Street price targets range from $220 to $255, with multiple Buy ratings maintained

Palantir (PLTR) CEO Alex Karp used a CNBC interview this week to draw a hard line between what frontier AI labs do and what Palantir actually delivers inside enterprises.


PLTR Stock Card
Palantir Technologies Inc., PLTR

PLTR stock was up 0.64% in premarket Thursday, trading around $131.04. That comes after a rough stretch — the stock is down 14.43% over the past week and 26.75% year to date, well behind the S&P 500 over both periods.

Karp’s comments came as Anthropic moves closer to a U.S. IPO. The Claude maker filed on June 1 and was last valued at $965 billion post-money — more than double its $380 billion valuation from February.

Karp wasn’t backing down from the comparison. He said enterprise AI is about more than having a good model or smart engineers.

AI’s Wealth Warning

Beyond the Anthropic jab, Karp raised a broader concern about what AI does to the economy.

He said the real issue isn’t just job losses — it’s that governments and businesses haven’t been honest about the scale of disruption coming.

PLTR Stock and Valuation

The technical picture for Palantir isn’t pretty right now. The stock trades below its 10, 50, 100, and 200-day moving averages — sitting nearly 18.6% below its 200-day SMA. A death cross formed in February, and MACD remains below its signal line.

Valuation is also a sticking point. PLTR trades at 90.24 times forward non-GAAP earnings — around 260% above the sector median.

Despite that, several Wall Street analysts are sticking with their bullish calls. BofA Securities maintains a Buy rating with a $255 price target. Wedbush holds its Outperform with a $230 target. Citi raised its target to $225, and Rosenblatt lifted theirs to $225 as well. Loop Capital reiterated a Buy at $220.

For context on the scale of opportunity: Gartner forecasts worldwide AI spending will hit $2.59 trillion in 2026. Palantir expects 2026 revenue of $7.65–$7.66 billion — about 1/339th of that total, after Q1 revenue jumped 39% year over year to $1.63 billion.

Key resistance sits at $149.50. Key support is at $128.50, near the lower end of the 52-week range of $122.68 to $207.52.

The post Palantir (PLTR) Stock: CEO Karp Says Anthropic Is “Running on Palantir” — Investors Take Note appeared first on CoinCentral.

Market Opportunity
Overtake Logo
Overtake Price(TAKE)
$0.01843
$0.01843$0.01843
+0.21%
USD
Overtake (TAKE) Live Price Chart

Predict & Trade to Win Rewards

Predict & Trade to Win RewardsPredict & Trade to Win Rewards

Guaranteed rewards with $500,000 prize pool

Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact [email protected] for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.

RealStocks Now Live

RealStocks Now LiveRealStocks Now Live

Trade real U.S. stock via regulated brokerage